Literature DB >> 30972688

Metabolic stroke in a patient with bi-allelic OPA1 mutations.

Ayelet Zerem1,2, Keren Yosovich3, Yael Cohen Rappaport4, Stephanie Libzon4, Lubov Blumkin4,5, Liat Ben-Sira5,6, Dorit Lev5,3, Tally Lerman-Sagie4,5.   

Abstract

OPA1 related disorders include: classic autosomal dominant optic atrophy syndrome (ADOA), ADOA plus syndrome and a bi-allelic OPA1 complex neurological disorder. We describe metabolic stroke in a patient with bi-allelic OPA1 mutations. A twelve-year old girl presented with a complex neurological disorder that includes: early onset optic atrophy at one year of age, progressive gait ataxia, dysarthria, tremor and learning impairment. A metabolic stroke occurred at the age of 12 years. The patient was found to harbor a de novo heterozygous frame shift mutation c.1963_1964dupAT; p.Lys656fs (NM_015560.2) and a missense mutation c.1146A > G; Ile382Met (NM_015560.2) inherited from her mother. The mother, aunt, and grandmother are heterozygous for the Ile382Met mutation and are asymptomatic. The co-occurrence of bi-allelic mutations can explain the severity and the early onset of her disease. This case adds to a growing number of patients recently discovered with bi-allelic OPA1 mutations presenting with a complex and early onset neurological disorder resembling Behr syndrome. To the best of our knowledge metabolic stroke has not been described before as an OPA1 related manifestation. It is important to be aware of this clinical feature for a prompt diagnosis and consideration of available treatment.

Entities:  

Keywords:  Behr syndrome; Metabolic stroke; Mitochondrial disease; Neurodegenerative disorder; Next generation sequencing; Optic atrophy

Mesh:

Substances:

Year:  2019        PMID: 30972688     DOI: 10.1007/s11011-019-00415-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  21 in total

Review 1.  OPA1-associated disorders: phenotypes and pathophysiology.

Authors:  Patrizia Amati-Bonneau; Dan Milea; Dominique Bonneau; Arnaud Chevrollier; Marc Ferré; Virginie Guillet; Naïg Gueguen; Dominique Loiseau; Marie-Anne Pou de Crescenzo; Christophe Verny; Vincent Procaccio; Guy Lenaers; Pascal Reynier
Journal:  Int J Biochem Cell Biol       Date:  2009-04-21       Impact factor: 5.085

Review 2.  Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders.

Authors:  Valerio Carelli; Chiara La Morgia; Maria Lucia Valentino; Piero Barboni; Fred N Ross-Cisneros; Alfredo A Sadun
Journal:  Biochim Biophys Acta       Date:  2009-03-05

3.  Expanding the phenotype of TRAK1 mutations: hyperekplexia and refractory status epilepticus.

Authors:  Shira Sagie; Tally Lerman-Sagie; Snezana Maljevic; Keren Yosovich; Katja Detert; Seo-Kyung Chung; Mark I Rees; Holger Lerche; Dorit Lev
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

4.  Early-onset Behr syndrome due to compound heterozygous mutations in OPA1.

Authors:  Dominique Bonneau; Estelle Colin; Florine Oca; Marc Ferré; Arnaud Chevrollier; Naïg Guéguen; Valérie Desquiret-Dumas; Sylvie N'Guyen; Magalie Barth; Xavier Zanlonghi; Marlène Rio; Isabelle Desguerre; Christine Barnerias; Marta Momtchilova; Diana Rodriguez; Abdelhamid Slama; Guy Lenaers; Vincent Procaccio; Patrizia Amati-Bonneau; Pascal Reynier
Journal:  Brain       Date:  2014-07-10       Impact factor: 13.501

5.  8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.

Authors:  Rebecca D Ganetzky; Marni J Falk
Journal:  Mol Genet Metab       Date:  2018-02-02       Impact factor: 4.797

Review 6.  Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.

Authors:  Bo Young Chun; Joseph F Rizzo
Journal:  Semin Pediatr Neurol       Date:  2017-06-30       Impact factor: 1.636

7.  Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.

Authors:  C Delettre; G Lenaers; J M Griffoin; N Gigarel; C Lorenzo; P Belenguer; L Pelloquin; J Grosgeorge; C Turc-Carel; E Perret; C Astarie-Dequeker; L Lasquellec; B Arnaud; B Ducommun; J Kaplan; C P Hamel
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

8.  Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.

Authors:  Chunyan Liao; Neil Ashley; Alan Diot; Karl Morten; Kanchan Phadwal; Andrew Williams; Ian Fearnley; Lyndon Rosser; Jo Lowndes; Carl Fratter; David J P Ferguson; Laura Vay; Gerardine Quaghebeur; Isabella Moroni; Stefania Bianchi; Costanza Lamperti; Susan M Downes; Kamil S Sitarz; Padraig J Flannery; Janet Carver; Eszter Dombi; Daniel East; Matilde Laura; Mary M Reilly; Heather Mortiboys; Remko Prevo; Michelangelo Campanella; Matthew J Daniels; Massimo Zeviani; Patrick Yu-Wai-Man; Anna Katharina Simon; Marcela Votruba; Joanna Poulton
Journal:  Neurology       Date:  2016-12-14       Impact factor: 9.910

Review 9.  Understanding the Epilepsy in POLG Related Disease.

Authors:  Omar Hikmat; Tom Eichele; Charalampos Tzoulis; Laurence A Bindoff
Journal:  Int J Mol Sci       Date:  2017-08-24       Impact factor: 5.923

10.  Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation.

Authors:  Ronen Spiegel; Ann Saada; Padraig J Flannery; Florence Burté; Devorah Soiferman; Morad Khayat; Verónica Eisner; Eugene Vladovski; Robert W Taylor; Laurence A Bindoff; Avraham Shaag; Hanna Mandel; Ora Schuler-Furman; Stavit A Shalev; Orly Elpeleg; Patrick Yu-Wai-Man
Journal:  J Med Genet       Date:  2015-11-11       Impact factor: 6.318

View more
  6 in total

1.  Pathogenicity evaluation and the genotype-phenotype analysis of OPA1 variants.

Authors:  Xingyu Xu; Panfeng Wang; Xiaoyun Jia; Wenmin Sun; Shiqiang Li; Xueshan Xiao; J Fielding Hejtmancik; Qingjiong Zhang
Journal:  Mol Genet Genomics       Date:  2021-04-21       Impact factor: 3.291

Review 2.  Biallelic Optic Atrophy 1 (OPA1) Related Disorder-Case Report and Literature Review.

Authors:  Bayan Al Othman; Jia Ern Ong; Alina V Dumitrescu
Journal:  Genes (Basel)       Date:  2022-06-02       Impact factor: 4.141

Review 3.  Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches.

Authors:  Michela Di Nottia; Daniela Verrigni; Alessandra Torraco; Teresa Rizza; Enrico Bertini; Rosalba Carrozzo
Journal:  Genes (Basel)       Date:  2021-02-10       Impact factor: 4.096

Review 4.  The Role of Mitochondrial Dynamin in Stroke.

Authors:  Chenchen Li; Chunli Chen; Haiyun Qin; Chuncao Ao; Jinlun Chen; Jieqiong Tan; Liuwang Zeng
Journal:  Oxid Med Cell Longev       Date:  2022-05-06       Impact factor: 6.543

5.  Altered Mitochondrial Opa1-Related Fusion in Mouse Promotes Endothelial Cell Dysfunction and Atherosclerosis.

Authors:  Ahmad Chehaitly; Anne-Laure Guihot; Coralyne Proux; Linda Grimaud; Jade Aurrière; Benoit Legouriellec; Jordan Rivron; Emilie Vessieres; Clément Tétaud; Antonio Zorzano; Vincent Procaccio; Françoise Joubaud; Pascal Reynier; Guy Lenaers; Laurent Loufrani; Daniel Henrion
Journal:  Antioxidants (Basel)       Date:  2022-05-28

6.  Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity.

Authors:  Juan Manuel Chao de la Barca; Mario Fogazza; Michela Rugolo; Stéphanie Chupin; Valentina Del Dotto; Anna Maria Ghelli; Valerio Carelli; Gilles Simard; Vincent Procaccio; Dominique Bonneau; Guy Lenaers; Pascal Reynier; Claudia Zanna
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.